DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Current Clinical Trials


Paclitaxel Related Clinical Trials

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Active, not recruiting]

A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. [Recruiting]

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors [Recruiting]

Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel [Recruiting]

A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer [Withdrawn]

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Completed]

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Completed]

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) [Active, not recruiting]

Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer [Terminated]

Hepatic Arterial Infusion (HAI) of Abraxane [Active, not recruiting]

Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting [Recruiting]

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 [Active, not recruiting]

Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 and Nab®-Paclitaxel Monotherapy as Second Line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer [Recruiting]

Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer [Recruiting]

Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A [Not yet recruiting]

Schedules of Nab-Paclitaxel in Metastatic Breast Cancer [Active, not recruiting]

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [Active, not recruiting]

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer [Completed]

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer [Recruiting]

Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments [Recruiting]

Study of Vemurafenib, Carboplatin, and Paclitaxel [Recruiting]

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors [Active, not recruiting]

HSP90 Inhibitor AT13387 and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer [Not yet recruiting]

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Completed]

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer [Recruiting]

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response [Recruiting]

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer [Recruiting]

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients [Recruiting]

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma [Completed]

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver [Completed]

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies [Recruiting]

MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer [Active, not recruiting]

Study Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto) [Active, not recruiting]

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer [Completed]

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) [Active, not recruiting]

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma [Recruiting]

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Completed]

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Recruiting]

Study of Afuresertib Combined With Paclitaxel in Gastric Cancer [Recruiting]

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma [Terminated]

Lenalidomide and Paclitaxel in Prostate Cancer [Active, not recruiting]

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer [Recruiting]

Phase IB/II Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer [Recruiting]

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer [Recruiting]

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel [Recruiting]

Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers [Recruiting]

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma [Recruiting]

Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement [Completed]

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer [Withdrawn]

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma [Completed]

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment [Completed]

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer [Recruiting]

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer [Completed]

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Active, not recruiting]

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer [Recruiting]

Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer [Terminated]

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer [Recruiting]

Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer [Recruiting]

Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer [Active, not recruiting]

A Phase I/II Study of Nab-Paclitaxel, or Paclitaxel, Plus Carboplatin With Concurrent Radiation Therapy Followed by Consolidation in Patients With Favorable Prognosis Inoperable Stage IIIA/B NSCLC [Recruiting]

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer [Completed]

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Recruiting]

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer [Recruiting]

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies [Active, not recruiting]

Prevention of Paclitaxel Neuropathy With Cryotherapy [Recruiting]

Cisplatin vs Paclitaxel for Triple Neg [Recruiting]

LDE225 and Paclitaxel in Solid Tumors [Active, not recruiting]

Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer [Recruiting]

To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Recruiting]

MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer [Active, not recruiting]

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients [Recruiting]

Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty [Completed]

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) [Recruiting]

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer [Recruiting]

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer [Active, not recruiting]

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation [Active, not recruiting]

Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) [Not yet recruiting]

Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer [Completed]

Treatment With Nab-paclitaxel in Cutaneous SCC [Not yet recruiting]

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer [Active, not recruiting]

First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer [Active, not recruiting]

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus [Withdrawn]

Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease [Completed]

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia [Recruiting]

Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma [Recruiting]

Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm [Recruiting]

Safety, Feasibility and Effect of TTFields Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma [Recruiting]

Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) [Completed]

Single Arm on the Tolerability of Weekly Nab-paclitaxel [Recruiting]

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017